What is a molecular glue and its role in drug development?

Molecular glue is a small molecule that induces or stabilizes interactions between two proteins, regulating biological processes. In drug development, it is mainly used in targeted protein degradation (TPD) to recruit E3 ubiquitin ligases for selective protein degradation. BOC Sciences provides high-purity molecular glues and custom synthesis services to accelerate early-stage drug discovery and mechanistic studies.

How does a molecular glue differ from PROTACs?

PROTACs are bifunctional molecules linking a target protein to an E3 ligase, whereas molecular glues are single small molecules that enhance or create protein-protein interactions for the same degradation effect. Molecular glues generally have smaller size and better pharmacokinetics. BOC Sciences offers both PROTAC and molecular glue supply and custom development services to support fast experimental access.

How are effective molecular glue candidates screened?

Screening typically involves protein-E3 binding assays (SPR, ITC), cellular degradation assays, and structural optimization. High-throughput screening (HTS) and computer-aided drug design (CADD) improve hit rates. BOC Sciences provides chemical libraries and custom synthesis to support candidate screening and structural optimization, reducing R&D risk.

What challenges do molecular glues face in clinical development?

Challenges include target specificity, pharmacokinetics, and biological complexity across cell types. BOC Sciences offers high-purity compounds, custom synthesis, and early ADME/Tox support to help evaluate candidate feasibility.

Which disease areas are suitable for molecular glue drug development?

Molecular glues show potential in cancer, autoimmune diseases, and neurodegenerative disorders by selectively degrading disease-relevant proteins. BOC Sciences supports clients with compound supply and custom development services across research to preclinical stages.